Immunic to host virtual relapsing multiple sclerosis R&D day

PUBT · 3d ago
Immunic to host virtual relapsing multiple sclerosis R&D day
  • Immunic will host a virtual relapsing multiple sclerosis R&D Day on Sept. 9, 2026.
  • Webinar scheduled for 11:00 a.m. to 12:30 p.m. ET via Zoom.
  • Event will focus on vidofludimus calcium (IMU-838), its lead Phase 3 relapsing MS program.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immunic Inc. published the original content used to generate this news brief via EQS News (Ref. ID: corporate_2389856_en) on September 02, 2026, and is solely responsible for the information contained therein.